Charter Oak Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Charter Oak Capital Management's PFE Position: Q1 2026 in Review
Charter Oak Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 10,926 shares — an estimated $272K sold.
Charter Oak Capital Management first reported a position in PFE in Q4 2020 and held it in 21 quarters. The position peaked at $660K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Charter Oak Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Charter Oak Capital Management sold 10,926 Pfizer shares in Q1 2026, an estimated $272K.
- Charter Oak Capital Management first reported a position in Pfizer in Q4 2020 and held it in 21 quarters.
- Charter Oak Capital Management's Pfizer position peaked at $660K in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.